NL2000247C2

Capsule for coffee pod, has water disintegratable wall provided with hydrophobic coating on the inside

Abstract

The inner side of the capsule wall is provided with a hydrophobic coating. A capsule having a wall which disintegrates or becomes permeable when brought into contact with water has a volume of 0.3-8 ml and is filled with an aqueous liquid. The inside of the capsule wall is provided with a hydrophobic coating. An independent claim is also included for a coffee pod comprising an enclosed casing which contains ground coffee and which is water-permeable but retains the coffee, the pod also containing the capsule.

Term

No projected expiry on record.

  1. Priority and filed
  2. Granted
  3. Today

18 claims: 11 independent, 7 dependent

  1. 1
    CONCLUSIES CONCLUSIONS 1. A liquid-containing capsule whose capsule wall decomposes or becomes permeable when contacted with hot water, the capsule having an internal volume of 0.3-8 ml filled with 0.3-8 ml of an aqueous liquid composition, characterized in that the inside of the capsule wall is provided with a hydrophobic coating. 1. Een vloeistofhoudende capsule waarvan de capsulewand uiteenvalt of permeabel wordt indien deze in contact gebracht wordt met heet water, welke capsule een inwendig volume heeft van 0.3-8 ml dat gevuld is met 0.3-8 ml van een waterige vloeibare samenstelling, met het kenmerk dat de binnenkant van de capsulewand voorzien is van een hydrofobe bekleding.
  2. 4
    Capsule according to any one of the preceding claims, characterized in that the aqueous liquid composition contains 0.2-20 wt.% Protein, preferably 0.5-10 wt.% Milk protein. 4. Capsule volgens één van de voorgaande conclusies, met het kenmerk dat de waterige vloeibare samenstelling 0.2-20 gew.% eiwit, bij voorkeur 0.5-10 gew.% melkeiwit bevat.
  3. 5
    Capsule according to any one of the preceding claims, characterized in that the liquid composition contains at least 80% by weight of milk components, based on dry weight. 5. Capsule volgens één van de voorgaande conclusies, met kenmerk dat de vloeibare samenstelling tenminste 80 gew.% melkbestanddelen bevat, berekend op drooggewicht.
  4. 6
    Capsule according to any one of the preceding claims, characterized in that the capsule contains 0.5-2.5 ml of the liquid composition. 6. Capsule volgens één van de voorgaande conclusies, met het kenmerk dat de capsule 0.5-2.5 ml van de vloeibare samenstelling bevat.
  5. 7
    Capsule according to any one of the preceding claims, characterized in that the capsule wall is made of gelatin and / or hydroxypropyl methyl cellulose. 7. Capsule volgens één van de voorgaande conclusies, met het kenmerk dat de capsulewand is vervaardigd uit gelatine en/of hydroxypropyl methyl cellulose.
  6. 9
    Capsule according to any one of the preceding claims, characterized in that the hydrophobic coating contains at least 80% by weight of one or more of the following components:triglycerides;diglycerides;hexa, hepta or octa esters of sucrose and fatty acids;waxes, alcohol esters and edible mineral oils. 9. Capsule volgens één van de voorgaande conclusies, met het kenmerk dat de hydrofobe bekleding tenminste 80 gew.% van één of meer van dc volgende componenten bevat: triglyceriden;diglyceriden;hexa-, hepta- ofocta-esters van sucrose en vetzuren;wassen, alcohol esters en eetbare minerale oliën.
  7. 11
    Capsule according to any one of the preceding claims, characterized in that the hydrophobic coating has a melting point of more than 25 ° C, preferably more than 30 ° C. 11. Capsule volgens één van de voorgaande conclusies, met het kenmerk dat de hydrofobe bekleding een smeltpunt heeft van meer dan 25 °C, bij voorkeur van meer dan 30 °C.
  8. 12
    Capsule according to any one of the preceding claims, characterized in that the capsule has a disc shape. 12. Capsule volgens één van de voorgaande conclusies, met het kenmerk dat de capsule een discusvorm bezit.
  9. 14
    Capsule according to any one of the preceding claims, characterized in that the capsule wall consists of two halves fused together. 14. Capsule volgens één van de voorgaande conclusies, met het kenmerk, dat de capsulewand bestaat uit twee helften die met elkaar versmolten zijn.
  10. 15
    Use of a capsule according to any of the preceding claims in a hot edible or drinkable liquid, preferably hot coffee. 15. Toepassing van een capsule volgens één van de voorgaande conclusies in een hete eetbare of drinkbare vloeistof, bij voorkeur hete koffie.
  11. 18
    A coffee bag comprising a closed casing with ground coffee therein, said casing being water-permeable but not permeable to the ground coffee, characterized in that the coffee bag further contains a capsule according to any one of claims 1-14. 18. Een koffiebuil die een gesloten omhulling met daarin gemalen koffie omvat, welke omhulling waterdoorlatend maar niet permeabel voor de gemalen koffie is, met het kenmerk dat de koffiebuil verder een capsule volgens één van de conclusies 1-14 bevat. COOPERATION TREATY (PCT) SAMENWERKINGSVERDRAG (PCT) RAPPORT BETREFFENDE NIEUWHEIDSONDERZOEK VAN INTERNATIONAAL TYPE REPORT ON NEWNESS RESEARCH OF INTERNATIONAL TYPE Form PCT / ISA 201 A (11/2000) Form PCT/ISA 201 A (11/2000) REPORT OF THE NEWNESS RESEARCH OF VERSLAG VAN HET NIEUWHEIDSONDERZOEK VAN INTERNATIONAAL TYPE INTERNATIONAL TYPE Number of the request for a novelty search Nummer van hel verzoek om een nieuwheidsonderzoek Form PCT / ISA / 201 (second btad) (January 2004) page 1 of 2 Formulier PCT/ISA/201 (tweede btad) (Januari 2004) bladzijde 1 van 2 REPORT OF THE NEWNESS RESEARCH OF VERSLAG VAN HET NIEUWHEIDSONDERZOEK VAN Number of the request for a novelty search Nummer van het verzoek om een nieuwheidsonderzoek INTERNATIONAAL TYPE INTERNATIONAL TYPE Form PCT / ISA <201 (continuation second page) (January 2004) page 2 of 2 Formulier PCT/ISA<201 (vervolg tweede blad) (Januari 2004) bladzijde 2 van 2 WRITTEN OPINION WRITTEN OPINION NETHERLANDS PATENT CENTER OCTROOICENTRUM NEDERLAND This opinion contains indications relating to the following items:This opinion contains indications relating to the following items: □ Box No. I □ Box No. II □ Box No. Ill □ Box No. IV M Box No. V □ Box No. VI □ Box No. VII □ Box No. VIII □ Box No. I □ Box No. II □ Box No. Ill □ Box No. IV M Box No. V □ Box No. VI □ Box No. VII □ Box No. VIII Basis of the opinion Basis of the opinion Priority Priority Non-establishment of opinion with regard to novelty, inventive step and industrial applicability Lack of unity of invention Non-establishment of opinion with regard to novelty, inventive step and industrial applicability Lack of unity of invention Reasoned statement with regard to novelty, inventive step or industrial applicability;citations and explanations supporting such statement Reasoned statement with regard to novelty, inventive step or industrial applicability;citations and explanations supporting such statement Certain documents cited Certain documents cited Certain defects in the application Certain defects in the application Certain observations on the application Certain observations on the application Examiner Examiner Saunders, Thomas Saunders, Thomas I I I__________ I__________ Form (NL237A) (Cover page) (July 2006) Form (NL237A) (Dekblad) (July 2006) Application number Application number WRITTEN OPINION WRITTEN OPINION Box No. I Basic ot this opinion Box No. I Basis ot this opinion 1. This opinion has been established on the basis of the latest set of claims filed before the start of the search. 1. This opinion has been established on the basis of the latest set of claims filed before the start of the search. 2. With regard to any nucleotide and / or amino acid sequence disclosed in the application and necessary to the claimed invention, this opinion has been established on the basis of: 2. With regard to any nucleotide and/or amino acid sequence disclosed in the application and necessary to the claimed invention, this opinion has been established on the basis of: a. type of material: a. type of material: □ a sequence listing □ table (s) related to the sequence listing □ a sequence listing □ table(s) related to the sequence listing b. format of material. b. format of material. On paper in electronic form □ on paper □ in electronic form c. time of filing / furnishing: c. time of filing/furnishing: Contained in the application as filed. □ contained in the application as filed. □ filed together with the application in electronic form. □ filed together with the application in electronic form. Furnished subsequently for the purposes of search. □ furnished subsequently for the purposes of search. 3. □ In addition, in the case that more than one version or copy of a sequence listing and / or table relating thereto has been filed or furnished, the required statements that the information in the subsequent or additional copies is identical to that in the application as filed or does not go beyond the application as filed, as appropriate, were furnished. 3. □ In addition, in the case that more than one version or copy of a sequence listing and/or table relating thereto has been filed or furnished, the required statements that the information in the subsequent or additional copies is identical to that in the application as filed or does not go beyond the application as filed, as appropriate, were furnished. 4. Additional comments: 4. Additional comments: Box No. V Reasoned statement with regard to novelty, inventive step or industrial applicability;citations and explanations supporting such statement Box No. V Reasoned statement with regard to novelty, inventive step or industrial applicability;citations and explanations supporting such statement 1. Statement 1. Statement 2. Citations and explanations see separate sheet 2. Citations and explanations see separate sheet NL237B (July 2006) NL237B (July 2006) WRITTEN OPINION (SEPARATE SHEET) WRITTEN OPINION (SEPARATE SHEET) Application number Application number Re Item V Re Item V Reasoned statement with regard to novelty, inventive step or industrial applicability;citations and explanations supporting such statement Reasoned statement with regard to novelty, inventive step or industrial applicability;citations and explanations supporting such statement 1. Reference is made to the following documents: 1. Reference is made to the following documents: D1: GB-A-191120321 D1: GB-A-191120321 D2: US-A-5362564 D2: US-A-5362564 D3: WO-A-2004/071899 D3: WO-A-2004/071899 2. Novelty 2. Novelty 2.1 The present application does not meet the criteria of patentability, because the subject-matter of claims 1-9, 15 and 16 is not new. 2.1 The present application does not meet the criteria of patentability, because the subject-matter of claims 1-9, 15 and 16 is not new. 2.2 The document D1 discloses (cf. page 1, lines 5-32) a milk or cream capsule for adding to a cup of coffee or tea, comprising a shell enclosing a portion of evaporated milk or cream, an intermediate coating of albumen (a water-soluble protein) around the shell and an outer coating of saccharine material (also water-soluble). The shell comprises gelatin or waxed paper, and the latter can be considered as a hydrophobic layer. 2.2 The document D1 discloses (cf. page 1, lines 5-32) a milk or cream capsule for adding to a cup of coffee or tea, comprising a shell enclosing a portion of evaporated milk or cream, an intermediate coating of albumen (a water-soluble protein) around the shell and an outer coating of saccharine material (also water-soluble). The shell comprises gelatine or waxed paper, and the latter can be regarded as a hydrophobic layer. D1 does not mention the internal volume of the capsule but since it is being used for the same purpose as the present invention, namely to add milk or cream to coffee, it would be expected that the internal volume will be within the range of 0.3- 8 ml and almost certainly within the range of 0.5-2.5 ml. D1 does not mention the internal volume of the capsule but since it is being used for the same purpose as the present invention, namely to add milk or cream to coffee, it would be expected that the internal volume will be within the range of 0.3-8 ml and almost certainly within the range of 0.5-2.5 ml. 2.3 D2 discloses (cf. Example 2) a liqueur capsule containing a liqueur with an alcohol content of 30%, therefore the liqueur will presumably contain approx. 70 wt.% Water. The capsule comprises a gelatin outer shell with an inner layer consisting of a fatty ester of sucrose. 2.3 D2 discloses (cf. Example 2) a liqueur capsule containing a liqueur with an alcohol content of 30%, therefore the liqueur will presumably contain ca. 70 wt.% water. The capsule comprises a gelatin outer shell with an inner layer consisting of a fatty ester of sucrose. The internal volume of the capsule is not disclosed but since the diameter is 3.2 mm it is assumed that it will be within the range of 0.5-2.5 ml. The internal volume of the capsule is not disclosed but since the diameter is 3.2 mm it is assumed that it will be within the range of 0.5-2.5 ml. 3. Inventive Step 3. Inventive Step Form NL237-3 (separate sheet) (July 2006) (sheet 1) Form NL237-3 (separate sheet) (July 2006) (sheet 1) WRITTEN OPINION (SEPARATE SHEET) WRITTEN OPINION (SEPARATE SHEET) Application number Application number 3.1 The present application does not meet the criteria of patentability, because the subjectmatter of claims 10-14 does not involve an inventive step. 3.1 The present application does not meet the criteria of patentability, because the subjectmatter of claims 10-14 does not involve an inventive step. 3.2 Dependent claims 10-14 define slight changes in the product of claim 1 which come within the scope of the customary practice followed by persons skilled in the art, especially as the advantages thus achieved can readily be foreseen. Consequently, the subject matter of these claims also lacks an inventive step. 3.2 Dependent claims 10-14 define slight changes in the product of claim 1 which come within the scope of the customary practice followed by persons skilled in the art, especially as the advantages thus achieved can readily be foreseen. Consequently, the subjectmatter of these claims also lacks an inventive step. 3.3 D1, however, does not mention the use of the milk or cream capsules for the preparation of coffee by percolating a combination of ground coffee and one of the capsules with hot water and the subject-matter of claim 17 can be considered to be novel and inventive. 3.3 D1, however, does not mention the use of the milk or cream capsules for the preparation of coffee by percolating a combination of ground coffee and one of the capsules with hot water and the subject-matter of claim 17 can be considered to be novel and inventive. 3.4 D3, considered to be the closest prior art with respect to claim 18, discloses (cf. Abstract) a pad from which the subject-matter of claim 18 differs in that the capsules as defined in claim 1 are present in the pad. 3.4 D3, considered to be the closest prior art with respect to claim 18, discloses (cf. Abstract) a pad from which the subject-matter of claim 18 differs in that the capsules as defined in claim 1 are present in the pad. The subject-matter of claim 18 is therefore to be considered as involving an inventive step for the same reasons as given in point (3.3) above. The subject-matter of claim 18 is therefore to be regarded as involving an inventive step for the same reasons as given in point (3.3) above. Form NL237-3 (separate sheet) (July 2006) (sheet 2) Form NL237-3 (separate sheet) (July 2006) (sheet 2) REPORT OF THE NEWNESS RESEARCH OF VERSLAG VAN HET NIEUWHEIDSONDERZOEK VAN INTERNATIONAAL TYPE INTERNATIONAL TYPE Informatie over leden van dezeltde octrooifamilie Information about members of the same patent family Number of the request for a novelty search Nummer van hel verzoek om een nieuwheidsonderzoek Formulier PCT/ISA/201 octrooifamilie) (Januari 2004) PCT / ISA / 201 patent family form) (January 2004)